These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 1740481)

  • 1. Abnormalities in circadian patterns of bone resorption and renal calcium conservation in type I osteoporosis.
    Eastell R; Calvo MS; Burritt MF; Offord KP; Russell RG; Riggs BL
    J Clin Endocrinol Metab; 1992 Mar; 74(3):487-94. PubMed ID: 1740481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the circadian variation in serum cortisol on markers of bone turnover and calcium homeostasis in normal postmenopausal women.
    Heshmati HM; Riggs BL; Burritt MF; McAlister CA; Wollan PC; Khosla S
    J Clin Endocrinol Metab; 1998 Mar; 83(3):751-6. PubMed ID: 9506720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skeletal responsiveness to endogenous parathyroid hormone in postmenopausal osteoporosis.
    Ebeling PR; Jones JD; Burritt MF; Duerson CR; Lane AW; Hassager C; Kumar R; Riggs BL
    J Clin Endocrinol Metab; 1992 Oct; 75(4):1033-8. PubMed ID: 1400868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circadian variation in ionized calcium and intact parathyroid hormone: evidence for sex differences in calcium homeostasis.
    Calvo MS; Eastell R; Offord KP; Bergstralh EJ; Burritt MF
    J Clin Endocrinol Metab; 1991 Jan; 72(1):69-76. PubMed ID: 1986029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
    Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
    J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of growth hormone administration on bone mineral metabolism, PTH sensitivity and PTH secretory rhythm in postmenopausal women with established osteoporosis.
    Joseph F; Ahmad AM; Ul-Haq M; Durham BH; Whittingham P; Fraser WD; Vora JP
    J Bone Miner Res; 2008 May; 23(5):721-9. PubMed ID: 18052753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nyctohemeral changes in bone turnover assessed by serum bone Gla-protein concentration and urinary deoxypyridinoline excretion: effects of growth and ageing.
    Eastell R; Simmons PS; Colwell A; Assiri AM; Burritt MF; Russell RG; Riggs BL
    Clin Sci (Lond); 1992 Sep; 83(3):375-82. PubMed ID: 1327658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of calcium intake in modulating age-related increases in parathyroid function and bone resorption.
    McKane WR; Khosla S; Egan KS; Robins SP; Burritt MF; Riggs BL
    J Clin Endocrinol Metab; 1996 May; 81(5):1699-703. PubMed ID: 8626819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis.
    Hodsman AB; Fraher LJ; Ostbye T; Adachi JD; Steer BM
    J Clin Invest; 1993 Mar; 91(3):1138-48. PubMed ID: 8450043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment.
    Garnero P; Shih WJ; Gineyts E; Karpf DB; Delmas PD
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1693-700. PubMed ID: 7989477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy?
    Langdahl BL; Loft AG; Møller N; Weeke J; Eriksen EF; Mosekilde L; Charles P
    J Bone Miner Res; 1997 Jan; 12(1):78-88. PubMed ID: 9240729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of parathyroid hormone in mediating nocturnal and age-related increases in bone resorption.
    Ledger GA; Burritt MF; Kao PC; O'Fallon WM; Riggs BL; Khosla S
    J Clin Endocrinol Metab; 1995 Nov; 80(11):3304-10. PubMed ID: 7593443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased PTH levels accompanied by low bone formation are associated with vertebral fractures in postmenopausal women with type 2 diabetes.
    Yamamoto M; Yamaguchi T; Nawata K; Yamauchi M; Sugimoto T
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1277-84. PubMed ID: 22337915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis.
    Ozmen B; Kirmaz C; Aydin K; Kafesciler SO; Guclu F; Hekimsoy Z
    Eur Cytokine Netw; 2007 Sep; 18(3):148-53. PubMed ID: 17823083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seasonal variation of biochemical indexes of bone turnover: results of a population-based study.
    Woitge HW; Scheidt-Nave C; Kissling C; Leidig-Bruckner G; Meyer K; Grauer A; Scharla SH; Ziegler R; Seibel MJ
    J Clin Endocrinol Metab; 1998 Jan; 83(1):68-75. PubMed ID: 9435418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate.
    Seibel MJ; Naganathan V; Barton I; Grauer A
    J Bone Miner Res; 2004 Feb; 19(2):323-9. PubMed ID: 14969403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An acute intake of phosphate increases parathyroid hormone secretion and inhibits bone formation in young women.
    Kärkkäinen M; Lamberg-Allardt C
    J Bone Miner Res; 1996 Dec; 11(12):1905-12. PubMed ID: 8970892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of short-term calcium depletion and repletion on biochemical markers of bone turnover in young adult women.
    Akesson K; Lau KH; Johnston P; Imperio E; Baylink DJ
    J Clin Endocrinol Metab; 1998 Jun; 83(6):1921-7. PubMed ID: 9626120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism.
    Rossini M; Gatti D; Isaia G; Sartori L; Braga V; Adami S
    J Bone Miner Res; 2001 Jan; 16(1):113-9. PubMed ID: 11149474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A defect in renal calcium conservation may contribute to the pathogenesis of postmenopausal osteoporosis.
    Heshmati HM; Khosla S; Burritt MF; O'Fallon WM; Riggs BL
    J Clin Endocrinol Metab; 1998 Jun; 83(6):1916-20. PubMed ID: 9626119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.